Quick Access

No journals followed

Browse journals

No saved papers

Feed Explore Journal Club Trending Questions Researchers

⌘K

ATNIVS biomarker heterogeneity in real-world patients receiving lecanemab | Synapse

April 15, 2026Open Access

ATNIVS biomarker heterogeneity in real-world patients receiving lecanemab

Key Points

The research aims to understand the variability of ATNIVS biomarker profiles in patients treated with lecanemab.
Assessment of ATNIVS biomarker profiles
Evaluation in a real-world patient setting
Qualitative analysis of biomarker heterogeneity
Substantial variability in ATNIVS biomarker profiles found
Implications for personalized treatment approaches
Data highlights the complexity of patient responses to lecanemab

Abstract

We identified substantial heterogeneity in ATNIVS biomarker profiles among patients receiving lecanemab in a real-world setting.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Loading...

Authors

M

Masanori Kurihara

R

Ryoko Ihara

G

Gen Yoshii

Journals

The Journal of Prevention of Alzheimer s Disease

Actions

Institutions

Nagasaki University

Tokyo Metropolitan Institute of Gerontology

Cognitive Neuroimaging Lab

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Loading...

Cite this study

Kurihara et al. (Sat,) studied this question.

www.synapsesocial.com/papers/69df2a4be4eeef8a2a6af768 — DOI: https://doi.org/10.1016/j.tjpad.2026.100567